Press alert
The Movember movement aims to raise awareness of male cancers and in particular prostate cancer. It is also an opportunity to talk about the medical experience of these men, who are confronted with a long medical course, dense with medical appointments and therapeutic obligations. Patients are often confronted with a lack of understanding of the disease and difficulties in finding answers to the questions they have, with shame or fear of disturbing health professionals despite possible after-effects of the treatment.
To relieve patients and encourage their involvement, one of the solutions that can be put in place by health establishments is the connected monitoring of their care via an application available directly on their mobile phone. This connected pathway allows for the monitoring of the patient's medical care, as well as an optimal evaluation of the side effects of the treatments and their impact on quality of life, and support for the patient's return to activity. For example, at the IPC in Marseille, 465 patients have been monitored in remission of their prostate cancer thanks to the application for the past two and a half years.
Based on this experience, why is it essential to develop connected patient pathway solutions for male cancers?
Christophe Rosso, co-founder of exolis, a company specialising in connected patient pathways which is helping 12 Cancer Centres to implement these solutions, and Dr Géraldine Pignot, urological surgeon at the Paoli-Calmettes Institute , discuss these issues:
- What follow-up for human cancers?
- How to strengthen the link with the medical team?
- What are the solutions to ensure patient access to information?
- Why set up a remote patient pathway?
- How can we ensure less intrusive monitoring for patients?
About exolis
exolis, an expert in the connected patient pathway, offers a complete, multi-service and multi-pathology patient portal that strengthens the link between the patient and the hospital. Designed for health establishments, institutions and general practitioners, exolis is a white-label partner in the digital transformation of the medical world.
The application is built around and for the patient, allowing him or her to enter a supervised care pathway in the institution and at home (making appointments, reception terminal, adapted and personalised medical follow-up, teleconsultation, online payments, electronic signature of consent, etc.). exolis works with a strong conviction: the involvement of the patient in all stages of his or her care pathway, even administrative, is a strong vector for therapeutic success.
Website: www.exolis.fr
About the Institut Paoli Calmettes (IPC)
Certified by the Haute Autorité de Santé (HAS) in 2015 level A, and accredited as a Comprehensive Cancer Center by the OECI (Organisation of European Cancer Institutes) in June 2019, the Institut Paoli-Calmettes is a member of the Unicancer network. The IPC brings together 1,800 medical and non-medical staff involved in the overall management of all cancer diseases: research, medical and support care, teaching and training. The IPC carried out more than 100,000 consultations and welcomed nearly 11,000 new patients in 2020. Treatment at the IPC is based exclusively on social security rates, and there are no extra fees. The IPC has established cooperation with some twenty health establishments in the region.
For more information: www.institutpaolicalmettes.fr
IPC press contact
Elisabeth BELARBI, Press Relations Officer
04 91 22 37 48 / 06 46 14 30 75 / belarbie@ipc.unicancer.fr
